MedPath
NMPA Approval

Vigabatrin Powder for Oral Solution

国药准字HJ20210049

June 25, 2021

Drug Information

氨己烯酸口服溶液用散

散剂

500mg

化学药品

June 25, 2021

June 24, 2026

Company Information

Applicant Company

71 Suttons Ln, Piscataway, NJ 08854 United States of America

Manufacturing Company

Steinbeisstrasse.1-2, Schorndorf, Baden-Wurttemberg 73614 GERMANY

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

氨己烯酸口服溶液用散 - NMPA 批准文号 | MedPath